A Case of Wet Age-Related Macular Degeneration Refractory to Aflibercept but Responsive to Systemic Everolimus

Canadian Journal of Ophthalmology - United States
doi 10.1016/j.jcjo.2019.05.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-Related Macular Degeneration

Korean journal of ophthalmology : KJO
Medicine
2016English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Burden of Wet Age-Related Macular Degeneration in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Results of Switchback From Ranibizumab to Aflibercept in Patients With Exudative Age-Related Macular Degeneration

Clinical Ophthalmology
Ophthalmology
2019English

Retinal Metabolic and Structural Alterations in Response to Aflibercept Treatment in Neovascular Age‐related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2018English

Pss3 - A Systematic Review and Meta-Analysis of Real-World Evidence Studies of Intravitreal Aflibercept in Wet Age-Related Macular Degeneration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Aflibercept in Age-Related Macular Degeneration: Evaluating Its Role as a Primary Therapeutic Option

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2017English

Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Age-Related Macular Degeneration

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy